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Conclusions: Preliminary data of this study suggest that CS
alone or in combination with GS is able to decrease signiﬁcantly
synovitis as measured by US. The decrease in synovitis after
SYSADOA treatment has been correlated with an improvement
in knee pain. The decrease in synovitis elicited by SYSADOA
treatment in this retrospective study is in accordance with former
reduction of synovitis signs shown by CS in other studies and
could contribute to explain its symptomatic and structure disease
modifying effects.
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Purpose: To determine the associations between serum levels of
inﬂammatory markers, radiographic osteoarthritis (OA) and knee
cartilage loss over time in older adults.
Methods: A total of 193 randomly selected subjects (mean 63
years, range 51-78, 47% female) were studied at baseline and 2.9
years later. Serum high-sensitivity C-reactive protein (hs-CRP),
interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) were as-
sessed by radioimmunoassay. T1-weighted fat-suppressed MRI of
the right knee was performed to determine knee cartilage volume.
Knee radiographic osteoarthritis (ROA) was also assessed.
Results: At baseline, quartiles of IL-6 and TNF-α were associated
with increased prevalence of medial tibiofemoral joint space nar-
rowing (grade ≥1) in multivariable analyses (IL-6: OR=1.41 and
1.49 per quartile; TNF-α: OR=1.62 and 1.49 per quartile for right
and left knees, respectively; all P<0.05). Longitudinally, baseline
IL-6 (not TNF-α) predicted loss in both medial and lateral tibial
cartilage volume (β: -0.87% and -1.02% per annum per quar-
tile, P<0.05 and P<0.01, respectively). An increase in IL-6 was
associated with increased loss of medial and lateral tibial carti-
lage volume (β: -0.89% and -0.78% per annum per quartile, both
P<0.05), and change in TNF-α was also negatively associated
with change in medial and lateral tibial cartilage volume (β: -0.75%
and -0.80% per annum per quartile, both P<0.05). The associa-
tions of IL-6 and TNF-α were dependent, in part, on each other
except those between baseline IL-6 and cartilage loss. Serum
hs-CRP was not associated with ROA and cartilage loss.
Conclusions: Serum levels of IL-6 and, to a lesser extent, TNF-α
are associated with knee cartilage loss in older people suggesting
low level inﬂammation plays a role in the pathogenesis of knee
OA.
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Purpose: African Americans with osteoarthritis (OA) report greater
pain and functional limitations than Caucasians, but the reasons
for these racial disparities are not well understood. This study
examined factors underlying racial differences in pain and function
among patients with hip and/or knee osteoarthritis (OA), including
psychological variables that have not previously been examined in
this context.
Methods: Participants were n=491 African Americans and Cau-
casians enrolled in a clinical trial of telephone-based OA self-
management. All measures were obtained at baseline. Pain and
function were assessed using the Arthritis Impact Measurement
Scales-2 (AIMS2) subscales. Potential explanatory variables in-
cluded demographic factors (age, gender, marital status, educa-
tion, income, working status, health literacy), health-related factors
(body mass index, self-reported health, joint(s) with OA, duration
of OA symptoms, pain medication use, current exercise), and
psychological factors (arthritis self-efﬁcacy, problem- and emotion-
focused pain coping, AIMS2 affect subscale). The AIMS2 pain
subscale was also included in models of AIMS2 function. Potential
explanatory variables that were associated with both race and
pain or function, and that reduced the association of race with
pain or function by ≥10%, were included in the ﬁnal multivariable
linear regression models where racial differences in AIMS2 pain
and function scores were examined.
Results: In unadjusted linear regression models, African Ameri-
can race was associated with higher (worse) AIMS2 pain scores
(unadjusted B = 0.65, p<0.01) and higher (worse) AIMS2 func-
tion scores (unadjusted B = 0.59, p<0.01). African American race
was no longer signiﬁcantly associated with AIMS2 pain scores in
the ﬁnal regression model (B = 0.03, p=0.874); variables signif-
icantly associated with worse AIMS2 pain scores in that model
were: worse AIMS2 affect scores, greater emotion-focused cop-
ing, lower arthritis self-efﬁcacy, and fair or poor self-reported
health. African American race was also no longer signiﬁcantly
associated with AIMS2 function scores in the ﬁnal regression
model (B = 0.07, p=0.509). Variables signiﬁcantly associated with
worse AIMS2 function scores were the same as those described
above for AIMS2 pain scores. In addition, worse AIMS2 pain
scores were signiﬁcantly associated with worse AIMS2 function
scores.
Conclusions: Factors explaining racial differences in pain and
function were largely psychological, including AIMS2 affect (which
comprises mood and level of tension), use of emotion-focused
coping, and arthritis self-efﬁcacy. Self-management and psycho-
logical/behavioral interventions can inﬂuence these factors, and
greater dissemination of these programs among African Amer-
icans may be a key step toward reducing racial disparities in
OA-related pain and function.
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Purpose: MicroRNAs are small non-coding RNAs that regulate
target messenger RNA. We investigated the implication of two
miRNAs, miR-140 and miR-27a, in MMP-13 and IGFBP-5 gene
regulation in human osteoarthritic (OA) chondrocytes.
Methods: Gene expression was determined by real-time PCR.
The effect of each miRNA on IGFBP-5 and MMP-13 expres-
sion/production was evaluated by transiently transfecting their pre-
cursors (pre-miRNAs) and inhibitors (anti-miRNAs) into human
OA chondrocytes. Modulation of IGFBP-5, miR-140 and miR-27a
